)
Visual
test
KP Tissue
KP Tissue (KPT) investor relations material
KP Tissue Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary18 Feb, 2026
Executive summary
Fiscal 2025 delivered strong revenue and profitability growth across Canadian and U.S. markets, supported by operational efficiency, safety improvements, and market share gains.
Adjusted EBITDA for Q4 2025 grew 26% year-over-year to $84.2 million, maintaining a run rate above CAD 80 million for a second consecutive quarter.
Net income for Q4 2025 was $23.4 million, reversing a net loss in Q4 2024.
Full-year 2025 revenue totaled $2,203.4 million, up 7.5%, with adjusted EBITDA of $318.2 million, up 20.2%.
Strategic investments, operational improvements, and product innovation supported growth and margin expansion.
Financial highlights
Q4 2025 revenue increased 3.8% year-over-year to $560.1 million, with gross margin improving to 19.3% from 14.9%.
Adjusted EBITDA margin rose to 15% from 12.4% year-over-year.
Net income margin for Q4 2025 was 4.2%.
Net debt decreased by $55.7 million sequentially, with leverage ratio improving to 3.1x.
Full-year net income improved to $75.5 million from $23.8 million in 2024.
Outlook and guidance
Q1 2026 Adjusted EBITDA is expected to be in line with Q4 2025.
2026 CapEx guidance raised to $100–$120 million, including spending for the new Memphis converting line and strategic projects.
Plans to announce a new TAD facility in the western U.S. in H1 2026, with operations targeted for 2028.
Continued focus on margin management and navigating economic volatility.
TAD project acceptable leverage ratio
What drives U.S. growth beyond new assets?
AFH segment long-term margin outlook
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from KP Tissue
- Record 2024 results, strong Q1 2025, new facility, and sustainability focus amid tariff risks.KPT
AGM 20252 Feb 2026 - Record financials, strategic expansions, and key risks addressed amid ongoing growth.KPTAGM 20242 Feb 2026
- Q2 revenue and EBITDA rose sharply, but net income fell as pulp costs and FX losses increased.KPTQ2 20241 Feb 2026
- Revenue up 10.1%, net income rose, but margins declined on higher costs.KPTQ3 202414 Jan 2026
- 2024 revenue topped $2B with robust EBITDA, but Q4 net loss reflects cost and FX pressures.KPTQ4 202424 Dec 2025
- Revenue, net income, and EBITDA grew, with U.S. expansion and Memphis investment supporting outlook.KPTQ2 202523 Nov 2025
- Q1 2025 saw double-digit revenue and EBITDA growth, with strong Consumer and U.S. sales.KPTQ1 202519 Nov 2025
- Q3 2025 delivered strong revenue and EBITDA growth, with a new U.S. plant announced for 2028.KPTQ3 202517 Nov 2025
Next KP Tissue earnings date
Q1 202613 May, 2026
KP Tissue
Next KP Tissue earnings date
Q1 202613 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage